Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06379568
Status:
COMPLETED
Last Update Posted:
2024-04-23
First Post:
2024-04-14
Brief Title:
Risk of Aspergillus Infection in Patients With Chronic Lung Disease
Sponsor:
Lin Chen
Organization:
Sichuan Provincial Peoples Hospital
Study Overview
Official Title:
Risk of Aspergillus Infection in Patients With Chronic Structural Lung Disease
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Large doses of systemic corticosteroids severe lung tissue damage and longer COPD diagnosis may increase the risk of IPA in patients with chronic structural lung disease By comparing the risk factors of aspergillus colonization group and aspergillus infection group the main risk factors of aspergillus pneumonia were determined
Detailed Description:
Patients with chronic lung disease were identified as positive for Aspergillus fumigatus through sputum microscopy According to diagnostic criteria patients diagnosed with IPA and CPA and were assigned to the Aspergillosis pneumonia group while the remaining patients were included in the Aspergillus colonization group ThenRisk factors for aspergillus pneumonia invasive pulmonary aspergillus disease and chronic pulmonary aspergillus disease such as the use of high-dose corticosteroids inhaled corticosteroids and the extent of damage to basic lung structures were identified by comparing the aspergillus colonization group with the aspergillus infection group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None